Sugi Predict

Sugi Predict / Targets / TMEM94

TMEM94

Transmembrane protein 94 · Q12767 · TMEM94 on Sugi Atlas →

0 patent compounds predicted against TMEM94, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to TMEM94 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Targeted Therapy With Glycogen Synthase Kinase-3 Inhibition for Arrhythmogenic Cardiomyopathy PHASE2RECRUITING
Targeting Endoplasmic Reticulum Stress in Human Hypertension PHASE1/PHASE2RECRUITING
Safety/Biomarker Study of CNTO 95 and Avastin in Solid Tumors PHASE1COMPLETED
Study of Oral CNF2024 (BIIB021) in Advanced Solid Tumors PHASE1COMPLETED
Safety and Pharmacology of SNX-5422 Plus Carboplatin and Paclitaxel in Subjects With Solid Tumors PHASE1COMPLETED
PBA Use for Treatment of ATF6-/- Patients EARLY_PHASE1SUSPENDED
Role of Sorcin and Annexin A3 in Breast Cancer Patients nanUNKNOWN
Evaluation of CEMIP in Pancreatic Cancer nanUNKNOWN
Clinical Application of PET Imaging Targeting GPA33 in Malignant Tumors nanNOT_YET_RECRUITING
Neutrophil FFA2/GPR43 Receptor Expression in Patients With the Diagnosis of Sepsis nanWITHDRAWN
Oat Bran and Plasma Lipid and Fecal Bacteria in Coronary Artery Disease Patients nanCOMPLETED
Renal Transporters After Renal Transplantation nanUNKNOWN
Avapritinib in the Treatment of Unresectable or Recurrent Metastatic GIST Non-exon18 Mutations of PDGFRA nanRECRUITING
Genetic Characterization of Parkinson's Disease nanCOMPLETED
Brain P-gp and Inflammation in People With Epilepsy nanCOMPLETED
MERC Proteins in Saliva and GCF in Periodontal Disease (ELISA Study) nanCOMPLETED
Characterization of New Candidate Genes in Cases of Human Inherited Thrombocytopenia (CATCH) nanCOMPLETED
Natural History of Photoreceptor Degeneration in USH1B: Clinical Parameters and Validation of Functional Vision Tests in MYO7A nanRECRUITING
MRI-phenotyping of Patients With Pathogenic Anoctamin 5 Variants nanRECRUITING
Clinical, Cellular, and Molecular Investigation Into Oculocutaneous Albinism nanCOMPLETED
Gene-STEPS: Shortening Time of Evaluation in Paediatric Epilepsy Services nanUNKNOWN
Registry and Natural History Study for Early Onset Hereditary Spastic Paraplegia nanRECRUITING
Role of TMEM219 Marker in Type 1 Diabetes nanUNKNOWN
Impact of Seasonal Malaria Chemoprevention on Immunity Against Malaria Among Children in Northern Benin nanCOMPLETED
Genetic Study of Age-Related Macular Degeneration nanCOMPLETED
Detection of Circulating Biomarkers of Immunogenic Cell Death nanCOMPLETED
Exercise on Expression of Heat Shock Protein 70 in Arterial Risk nanCOMPLETED
Microbiome Acquisition and Progression of Inflammation and Airway Disease in Infants and Children With Cystic Fibrosis nanCOMPLETED
Quantification of GADD34 Expression in RA nanCOMPLETED
Neutrophils as Prognostic Factors in Granulomatosis With Polyangiitis (Formerly Named Wegener's Granulomatosis) nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a TMEM94 binder may also engage these)

ProteinNameSimilarity
Q7TSH8 — 1.000 Q7TSH8 →
A2RT67 — 0.976 A2RT67 →
A4D1U4 — 0.973 A4D1U4 →
Q4FZX0 — 0.972 Q4FZX0 →
Q3UHG7 — 0.972 Q3UHG7 →
P58742 — 0.972 P58742 →
Q0PGW2 — 0.971 Q0PGW2 →
Q9UPU7 — 0.970 Q9UPU7 →
Q9C0I1 — 0.970 Q9C0I1 →
Q9H6J7 — 0.970 Q9H6J7 →
Q5XPI4 — 0.969 Q5XPI4 →
F1R7R1 — 0.969 F1R7R1 →
Q9NVU0 — 0.969 Q9NVU0 →
Q5RC14 — 0.969 Q5RC14 →
A7UA95 — 0.969 A7UA95 →
O75129 — 0.969 O75129 →
Q6NXD8 — 0.969 Q6NXD8 →
Q5R6S0 — 0.969 Q5R6S0 →
Q80TA6 — 0.968 Q80TA6 →
Q3U0J8 — 0.968 Q3U0J8 →
A2RUS2 — 0.968 A2RUS2 →
F1MDL2 — 0.968 F1MDL2 →
Q1LX49 — 0.968 Q1LX49 →
Q3UHE1 — 0.968 Q3UHE1 →
Q80U62 — 0.968 Q80U62 →
B1H268 — 0.968 B1H268 →
Q08BB3 — 0.968 Q08BB3 →
Q80VP0 — 0.968 Q80VP0 →
ABHD16A Phosphatidylserine lipase ABHD16A 0.967 landscape →
Q8C0R7 — 0.967 Q8C0R7 →